Monoclonal, anti-D has proved impossible to make in rodent systems. Human m
onoclonal anti-D has been produced using EBV transformed peripheral B cells
, coupled with fusions to myeloma cell lines. More recently molecular biolo
gy techniques have been used to produce monoclonal anti-D. The range of mon
oclonal anti-D produced is considered. The selection of monoclonal anti-D f
or use as blood grouping reagents for typing donors and recipients is revie
wed - all types of D positive should be typed as positive when donors are c
onsidered However, D patients should be typed as D negative. Considerations
for the development of monoclonal anti-D for prophylactic use are reviewed
.